Literature DB >> 7211203

Distribution of the neuronal specific protein, 14-3-2, in central nervous system lesions of tuberous sclerosis.

K Stefansson, R Wollmann.   

Abstract

The distribution of a neuronal specific enolase (14-3-2) in the central nervous system (CNS) lesions of tuberous sclerosis (TS) was examined using antiserum to 14-3-2 and the peroxidase antiperoxidase (PAP) method of Sternberger. In cortical tubers all the giant cells had intense cytoplasmic staining. Only occasional cells in the subependymal nodules were stained. All cells in the subependymal giant cell tumors were intensely stained. This indicates that the cortical giant cells and the giant cell subependymal tumors are of neuronal rather than astrocytic origin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7211203     DOI: 10.1007/bf00689991

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  13 in total

1.  Changes in the concentration of the brain specific protein 14-3-2, during the development of the superior cervical ganglion of the rat and effects of surgical decentralization.

Authors:  A Grasso; R Pirazzi
Journal:  Brain Res       Date:  1975-06-13       Impact factor: 3.252

2.  Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors.

Authors:  L F Eng; L J Rubinstein
Journal:  J Histochem Cytochem       Date:  1978-07       Impact factor: 2.479

3.  Expression of the neuron-specific protein, 14-3-2, and steroid sulfatase in neuroblastoma cell hybrids.

Authors:  F A McMorris; A R Kolber; B W Moore; A S Perumal
Journal:  J Cell Physiol       Date:  1974-12       Impact factor: 6.384

4.  The levels of the brain-specific proteins, S-100 and 14-3-2, in the developing chick spinal cord.

Authors:  T J Cicero; R R Provine
Journal:  Brain Res       Date:  1972-09-15       Impact factor: 3.252

5.  Regional changes in CNS levels of the S-100 and 14-3-2 proteins during development and aging of the mouse.

Authors:  T J Cicero; J A Ferrendelli; V Suntzeff; B W Moore
Journal:  J Neurochem       Date:  1972-09       Impact factor: 5.372

6.  Preparation and properties of the brain specific protein 14-3-2.

Authors:  A Grasso; G Roda; R A Hogue-Angeletti; B W Moore; V J Perez
Journal:  Brain Res       Date:  1977-04-01       Impact factor: 3.252

7.  Subependymal giant cell tumor of tuberose sclerosis. A light and ultrastructural study.

Authors:  J P de Chadarévian; R D Hollenberg
Journal:  J Neuropathol Exp Neurol       Date:  1979-07       Impact factor: 3.685

8.  Brain endolases as specific markers of neuronal and glial cells.

Authors:  D Schmechel; P J Marangos; A P Zis; M Brightman; F K Goodwin
Journal:  Science       Date:  1978-01-20       Impact factor: 47.728

9.  Distribution of glial fibrillary acidic protein in central nervous system lesions of tuberous sclerosis.

Authors:  K Stefansson; R Wollmann
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

10.  Ultrastructural localization of glial fibrillary acidic protein in mouse cerebellum by immunoperoxidase labeling.

Authors:  M Schachner; E T Hedley-Whyte; D W Hsu; G Schoonmaker; A Bignami
Journal:  J Cell Biol       Date:  1977-10       Impact factor: 10.539

View more
  10 in total

1.  Subependymal giant cell astrocytoma--a clinicopathological study of 23 cases with special emphasis on histogenesis.

Authors:  Mehar Chand Sharma; Angela Mercy Ralte; Shailesh Gaekwad; Vani Santosh; S K Shankar; Chitra Sarkar
Journal:  Pathol Oncol Res       Date:  2004-12-27       Impact factor: 3.201

2.  Medulloblastomas in childhood: histological factors influencing patients' outcome.

Authors:  K Taomoto; T Tomita; A J Raimondi; J E Leestma
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

3.  An immunohistochemical study of glial and neuronal markers in primary neoplasms of the central nervous system.

Authors:  J A Royds; J W Ironside; C B Taylor; D I Graham; W R Timperley
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

4.  Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors.

Authors:  E P Henske; L L Wessner; J Golden; B W Scheithauer; A O Vortmeyer; Z Zhuang; A J Klein-Szanto; D J Kwiatkowski; R S Yeung
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

5.  Biological behavior and tumorigenesis of subependymal giant cell astrocytomas.

Authors:  S K Kim; K C Wang; B K Cho; H W Jung; Y J Lee; Y S Chung; J Y Lee; S H Park; Y M Kim; G Choe; J G Chi
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

6.  Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology.

Authors:  P B Crino; J Q Trojanowski; M A Dichter; J Eberwine
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

7.  Subependymal giant cell astrocytoma. Significance and possible cytogenetic implications of an immunohistochemical study.

Authors:  J M Bonnin; L J Rubinstein; S C Papasozomenos; P J Marangos
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

8.  Subependymal giant-cell tumor: astrocytic or neuronal?

Authors:  Y Nakamura; L E Becker
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

9.  Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study.

Authors:  T Hirose; B W Scheithauer; M B Lopes; H A Gerber; H J Altermatt; M J Hukee; S R VandenBerg; J C Charlesworth
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Morphological substrates of infantile spasms: studies based on surgically resected cerebral tissue.

Authors:  H V Vinters; R S Fisher; M E Cornford; V Mah; D L Secor; M J De Rosa; Y G Comair; W J Peacock; W D Shields
Journal:  Childs Nerv Syst       Date:  1992-02       Impact factor: 1.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.